NTL Healthcare participated in the ‘6 International Advanced Medical Devices and Medical Industry Exhibition (KOAMEX 30)’ held at EXCO in Daegu for 7 days from Friday, June 2th to Sunday, July 3nd.
At this exhibition, NTL Healthcare mainly introduced the cervical cancer AI imaging diagnosis platform ‘Cervicale® AI (Cervicare AI)’. Servicare AI is cervical cancer imaging diagnosis software that assists medical staff in decision-making during cervical cancer screening. Based on 600 million cervical image big data, it is possible to distinguish between normal and abnormal cervix and subdivide normal into normal and atypical.
An official from NTL Healthcare said about Cervicare AI, “It is a system that diagnoses cervical cancer using artificial intelligence. Previously, it was done through remote examination, but real-time analysis is possible through imaging medical devices and images. “With a 27-year history, our company has a 70% share of the obstetrics and gynecology market and is currently supplying medical artificial intelligence solutions around the world, including exports to Thailand and Vietnam, as well as Mongolia and Costa Rica.”
NTL Healthcare has developed CerviCare AI, an AI imaging diagnosis platform for cervical cancer, CerviCARE®, a diagnosis platform for cervical and female diseases, and Dr. Dr. Cervicare, a cervical enlargement imaging device. We have experience introducing Cervicam C20, etc.
Meanwhile, the main exhibition items of ‘KOAMEX 2023’ hosted by Daegu Metropolitan City and K-MEDI Hub are as follows. △Diagnostic and diagnostic devices such as scanners, measuring devices, and imaging devices △Clinical and inspection devices △Surgical and recycling devices △Hospital facilities and emergency equipment △Medical devices, parts, and services △Pharmaceutical devices △Medical services, SW
→ Go to KOAMEX 2023 News Special Page
